Wed, Jul 23, 2014, 8:57 AM EDT - U.S. Markets open in 33 mins.

Recent

% | $
Click the to save as a favorite.

Neostem, Inc. Message Board

  • posgost67 posgost67 Jul 16, 2013 9:44 PM Flag

    UCSF collaboration is a huge deal

    Most if not all people here don't know this, but this is a huge deal. This is my 3rd time trying to post this, but I think I figured out why they keep taking it down because I posted a website maybe?? Last time trying. Anyway-Jeff Bluestone is the top type I diabetes researcher in the country. He is looking at taking cells called regulatory t cells, a controller of autoimmunity, from early diabetic patients (kids) and trying to see if he can expand and activate the cells to suppress their immune system. Also wants to do the same in patients at risk for diabetes to prevent the disease. Here's the skinny. Bluestone's lab(s) are a fine tuned machine. He has over 100 million in NIH grant money as he runs the UCSF translational science center. Not gonna post the website this time. But go to search browser and type "NIH Reporter" then Bluestone's name. His center has been likened to the NIH of the west, as his center can redistribute those funds to grant money to investigators with novel ideas. To my knowledge this is the highest funded center currently and the most money that the NIH gave to one center. For him to trust NBS with making the cells for his most important project is huge, and will give NBS a steady flow of large amounts of income. So suck it Anti-quated and stop posting. You make me tired with your garbage.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NBS
6.01+0.08(+1.35%)Jul 22 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.